# A Nordic Phase II Study of PTCL Based on Dose-intensive Induction and High-dose Consolidation With ASCT

> **NCT00791947** · PHASE2 · COMPLETED · sponsor: **University of Aarhus** · enrollment: 166 (actual)

## Conditions studied

- Peripheral T-Cell Lymphoma

## Interventions

- **DRUG:** CHOEP + G-CSF followed by BEAM

## Key facts

- **NCT ID:** NCT00791947
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-10
- **Primary completion:** 2008-08
- **Final completion:** 2010-08
- **Target enrollment:** 166 (ACTUAL)
- **Last updated:** 2011-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00791947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00791947, "A Nordic Phase II Study of PTCL Based on Dose-intensive Induction and High-dose Consolidation With ASCT". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00791947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*